During the past decade there has been a marked increase in the misuse of all types of drugs-from aspirin to penicillin. The most alarming increase has been in relation to the psychoactive drugs; particularly those with a high addictive potential. Broadly these can be considered under four main headings:
(i) the narcotics, e.g, heroin, morphine, pethidine and methadone; (ii) cerebral stimulants, e.g, cocaine, amphetamine and methyl-amphetamine, phenmetrazine and some anti-depressants, e.g, nortriptyline and imipramine; (iii) the sedatives, e.g, barbiturates, glutethimide and methaqualone; and (iv) the hallucinogens, e.g, cannabis and LSD. At present the routine clinical laboratory is mainly concerned with the problem of drug addiction at two points in time. Firstly, in the detection and identification of drug misuse by patients suspected on clinical grounds of suffering from self administered druginduced disease; and secondly, in the control, management and treatment of such patients. For the most part these are, at the present time, young people-generally between the ages of 15 and 25-who have become habituated to (or increasingly sporadically misuse) heroin and/or methylamphetamine.
Although the aim of treatment is ultimately to wean the patient of all addictive drugs and to maintain him in the drug-free state, this may not be possible; and even in the most favourable cases takes time and patience. In the interim it may be necessary and sufficient to substitute a less harmful for a more harmful drug, such as methadone for heroin; ephedrine for methyl-amphetamine.
Deceit and untruthfulness are, however, inseparable from drug misuse and the patient's history is virtually worthless; and clinicians looking after such patients should have available to them, objective evidence of their patient's continued drug use, or abuse, during treatment. At the present time this information can only be obtained by urine analysis.
For the past four years we have been examining, on a routine basis, urines from young heroin addicts for narcotics, amphetamines and occasionally for Paper read at the Southern EnaIand and South Wales Rqpon Mc:ctinll Halton, May, 1968 .
• 95 sedatives. Though highly desirable, the absence of any method-even at the research level-for detecting in biological fluids, either cannabis or LSD, makes this impossible. The method described here is that now used in our laboratory routinely for the detection and identification of narcotic and stimulant drugs in the urine of known or possible "users". It is based on the use of differential solvent extraction and of cation exchange paper or resin to effect removal and partial separation of drugs prior to thin layer (TLC) or gas liquid (GLC) chromatography (Beckett and Rowland, 1965; Dole et al., 1966; Beckett et al., 1967) .
Note that as heroin is rapidly deacylated in the body it virtually never appears in the urine except as morphine. Mix 950 ml. of saturated sodium borate solution with 50 mi. 0.3 N sodium hydroxide; check pH. 10. Isopropanol/chloroform solvent; 1 volume isopropanol and 3 volumes chloroform. 11. Iodoplatinate Reagent.
To 9 ml. of 10% potassium iodide add 1 ml. 5 % platinic chloride and 20 mi. water.
Procedure
1. Pipette 20 ml. of urine into a 50 ml. glass stoppered tube and adjust the pH to 6-7 with 5 N NaOH or 6 N HCI. 2. Add 0.4 ml. of 6 N HCl 3. Add 20 ml. diethyl ether and extract on a "Rolamix" for 10 minutes. Remove and allow the phases to separate. Discard the ether phase. 4. Add 2 ml, of 5 N NaOH and 20 ml, of diethyl ether to the residual urine. Methyl-amphetamine shows as a yellow spot, Rf about 58. For definitive identification of amphetamine and congeners further investigation is ESSENTIAL. In our experience Gas Liquid Chromatography of the original extract (Stage 6), using the technique of Becket et al. (1967) , is satisfactory.
(The metabolites of nortryptiline, arnitryptiline and imipramine (but not the pure parent compounds) have similar chromatographic and tinctorial properties on TLC but can be distinguished from amphetamine and methylamphetamine by G LC.] 12. Dilute the urine from stage 5 with 20 ml. of water and adjust the pH to 5-6 with 6 N HCI. 13. Take a 4 x 9 em. piece of Amberlite SA2 paper and insert into a polythene serviette ring. Immerse the paper, contained as a roll within the ring, into the diluted urine, stopper the tube and shake on a Kahn shaker for 30 minutes. 14. Tip off the urine and discard. 15. Rinse the paper with water. 16. Add 20 ml. pH 9.3 borate buffer, together with 20 ml. isopropanol/chloroform solvent. 17. Stopper the tube and mix on a Khan shaker for 10 minutes. 18. Take the tube from the shaker and remove the ion exchange paper and discard. Allow the two phases to separate. Suck off and discard the upper aqueous phase. 19. Add 1 g. of anhydrous sodium sulphate to the remaining organic phase and shake vigorously by hand for about 1 minute. 20. Filter into a 6 in. x 1 in. boiling tube; add 3-4 "anti-bumping" granules and evaporate down in a boiling water bath. 21. Spot the residue onto a TLC plate of silica gel G, using methyl alcohol as solvent. Also spot on 10 j-tg. of morphine standard. 22. Develop the plate in a solvent system consisting of ethyl acetate 170 rnl., methyl alcohol 20 ml. and concentrated ammonia solution 10 ml. 23. After development, dry the plate in an oven at 90°C to remove solvent. 24. Spray with iodoplatinate reagent diluted with equal parts (I :I) with 2 N HCI. Morphine shows up as a bright blue spot, Rf about 40 and Codeine as a blue-mauve spot, Rf about 60. Chromatograms prepared from urine of normal subjects are clear of all spots, but in addicts, and others taking drugs, various spots, due either to the unchanged drug or its metabolites (and which were not completely removed during the preparative stage) may also appear. These seldom give rise to difficulty, because of their position or colour, but in such cases it is nevertheless advisable to use at least one additional technique to identify the morphine spot. Dole et al. (1966) recommend overspraying with silver acetate when morphine shows up as a black spot. Davidow et al. (1966) overspray with Dragendorff's reagent when most of the spots fade but the morphine spot remains unchanged. In this laboratory we prefer to remove the spot from the plate, elute the morphine and determine its fluoro-97 metric emission and activation spectrum after conversion to pseudomorphine.
Alternative method for morphine using Zeokarb 225 (SRC13)
As Amberlite SA2 paper is not, at the time of this writing, commercially available, substitute materials were investigated. None of the four types of ion exchange paper that we tried was suitable, but the ion exchange resin Zeokarb 225 (SRC 13) proved to be equally as satisfactory as Amberlite SA2 paper. 13(a) 2-3 grams of Zeokarb 225 (SCR 13) sodium form, ion exchange resin is added to the diluted urine (from Stage 12). The tube is stoppered and mixed on a "Rolamix" for 15 minutes. 14(a) Decant the urine and discard. 
Notes and Comments
(1). The technique described, though more complicated to perform than many of the methods in the literature (Parker et aI., 1966; Dole et al., 1966; Harms, 1965 , Davidow et al., 1966 has nevertheless proved more suitable, in our hands, for the type of case often encountered in clinical practice in this country; namely one in which a large number of drugs are taken (often in large doses) in addition to those primarily being sought.
(2). The technique as described will detect the presence of "free" morphine (at a concentration of 1 j-tg./ml. or more). "Conjugated" morphine will only be detected if the urine is firstly hydrolysed. Besides increasing the complexity of the investigation it makes the interpretation of the resulting chromatograms more difficult, due to extraneous substances liberated by the hydrolytic process and not removed entirely by the preparative steps.
Nevertheless, because of the growing practice in this country of misusing heroin sporadically-rather than habitually-methods based solely upon the detection of "free" morphine in the urine may not always be sensitive enough to detect heroin misuse last practised more than 24 hours previously; and it may be necessary to increase the sensitivity by hydrolysis of urine prior to extraction and chromatography.
(3). "Conjugated" (but not "free") morphine appears in the urine after the ingestion of codeine. Provided this possibility is borne in mind it should not present difficulties in interpretation.
